Panic Disorders Market to reach USD 13.17 Billion by 2030
Global Panic Disorders Market survey report additionally encompasses predictions utilizing a practical arrangement of uncertainties and techniques. With this market report study, key opportunities in the market and influencing factors are provided which is useful to take the business to the highest level. By including detailed statistics and market research insights, this business report is generated, which results in high growth and thriving sustainability in the market for the businesses. An expert team analyses and forecasts market data using well established market statistical and coherent models to make Global Panic Disorders Market report outstanding.
Panic disorder is a mental and behavioral disorder characterized by recurrent, irrational panic attacks. These attacks involve symptoms such as palpitations, sweating, shaking, shortness of breath, numbness, and a sense of impending doom. Panic attacks reach their peak intensity within minutes. Stress and anxiety are common triggers for panic disorders. In a competitive and fast-paced world, individuals strive to excel, but the prevalence of panic disorders brings ongoing concerns and avoidance of triggering environments.
Data Bridge Market Research analyses that the panic disorders market, valued at USD 9.58 billion in 2022, will reach USD 13.17 billion by 2030, growing at a CAGR of 4.06% during the forecast period of 2023 to 2030. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. Type segment is dominating the global panic disorder market due to the availability of efficient treatment options. In growth In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-panic-disorders-market&Shri
Market Overview:
Recurrent, irrational panic attacks characterize a mental and behavioral disorder called panic disorder. In addition to palpitations, sweating, shaking, shortness of breath, numbness, or the impression that something terrible is about to happen, a panic attack, also known as an acute onset of severe fear, can include other symptoms. Within minutes, sensations reach their peak intensity. Anxiety and fear attacks that come on suddenly and repeatedly are signs of a panic disorder. Panic disorders can be caused by stress and anxiety. Almost every person aspires to be at the top of the game in this fast-paced world. The intense competition in the market makes it difficult even to stay afloat. There may be ongoing concerns about possible attacks and avoiding places where incidents have previously occurred.
Drivers
- Increasing Prevalence of Panic Disorders
The increasing prevalence of panic disorders in different parts of the world is an important market factor. Factors such as lifestyle changes, work-related stress, and increased awareness of mental health are increasing the number of people seeking diagnosis and treatment for panic disorders.
- Advancements in Treatment Options
The development of innovative treatment options, including medications, cognitive-behavioral therapies, and relaxation techniques, will contribute to the growth of the panic disorder market. Continuous research and technological development in the field lead to more effective and individualized treatment methods that expand the market.
- Growing Mental Health Awareness and Initiatives
Increasing public awareness about mental health issues, including panic disorders, and the efforts of governments, healthcare organizations, and advocacy groups to address mental health concerns are driving market growth. The rising recognition of panic disorders as a serious health condition is resulting in improved access to diagnosis and treatment options.
Recent Developments
- In 2022, patients with panic disorder, alone or in combination with the listed co-morbidities, are being studied in a multicenter, randomized, double-blind, and placebo-controlled Phase II trial. Between 18 and 60, male and female adult patients with panic disorder are enrolled in the study to compare the safety and efficacy of HB-1 to a placebo. By January 2023, completion is anticipated
- In 2022, top-line results from the Phase 2 Proof-of-Concept investigator-initiated trial of HMNC Brain Health’s oral prolonged-release ketamine (KET01) formulation in treating treatment-resistant depression (TRD) were encouraging
- In 2021, the effectiveness of Xenon Inhalation in treating patients with panic disorder was investigated in a double-blind, randomized, and placebo-controlled phase II and phase III trial. The findings indicate that Xenon is a promising therapeutic option for treating panic disorder and that its anti-panic effects persist for at least six months after the active phase of therapy.
Fundamental Aim of this Market Report
- Factors influencing This Market Size and growth rate.
- Major alterations to this market in the near future.
- Notable Market rivals around the world.
- Future Scope and Product Outlook
- Future-promising emerging markets.
- The Market Presents Difficult Challenges and Threats.
The Prominent Key Players Operating in the Global Panic Disorders Market Include:
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sun Pharmaceutical Industries Ltd. (India)
- Mylan N.V. (U.S.)
- AstraZeneca (U.K.)
- Abbott. (U.S.)
- Baxter. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Eli Lilly and Company. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- GlaxoSmithKline plc (U.K.)
- Noven Pharmaceuticals, Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Recordati S.p.A. (Italy)
- Shionogi & Co., Ltd. (Japan)
- Sumitomo Pharma Co., Ltd (Japan)
- Boehringer Ingelheim International GmbH. (Germany)
- Bausch Health Companies Inc. (Canada)
- H. Lundbeck A/S (Denmark)
- Sanofi (France)
- Neurocrine Biosciences, Inc (U.S.)
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-panic-disorders-market?Shri
Segmentation: Global Panic Disorders Market
The global panic disorders market is segmented on the basis of type, therapy and devices, drug class, distribution channel, administration, treatment, dosage, and end user.
- On the basis of type, the global panic disorders market is segmented into agoraphobia, social anxiety disorder (SAD), obsessive-compulsive disorder (OCD), bipolar disorder, post-traumatic stress disorder (PTSD), specific phobias, generalized anxiety disorder (gad), major depressive disorder (MDD).
- On the basis of therapy and devices, the global panic disorders market is segmented into electroconvulsive therapy ect, cognitive-behavioral therapy (CBT).
- On the basis of drug class, the global panic disorders market is segmented into benzodiazepines (BZD), serotonin-norepinephrine reuptake inhibitor (SNRI), monoamine oxidase inhibitors (MAOIS), anti-depressants, tricyclic antidepressants (TCAS), pregabalin, BUSPIRONE, sertraline.
- On the basis of distribution channel, the global panic disorders market is segmented into pharmacies, drug stores, e-commerce, online, offline.
- On the basis of administration, the global panic disorders market is segmented into oral, parental and others.
- On the basis of treatment, the global panic disorders market is segmented into medication, beta blockers, serotonin and norepinephrine reuptake inhibitors (snris), benzodiazepines, anti-epilepsy, others.
- On the basis of dosage, the global panic disorder market is segmented into tablets, injections, others.
- On the basis of end user, the global panic disorders market is segmented into hospitals, mental healthcare centres, asylums, others.
Regional Insights: North America is dominate the Global Panic Disorders Market
In North America, the U.S. holds a dominant position in the market for panic disorder treatments and is expected to maintain this trend of dominance throughout the forecast period. Factors such as the availability of diverse treatment options and the increasing healthcare costs contribute to the region’s rapid revenue growth. Moreover, the market in North America is projected to benefit from heightened awareness of panic disorder and related conditions.
In the Asia-Pacific region, particularly in developing nations, changing lifestyles, westernization, and modernization are driving factors for market growth. With countries like China and India experiencing significant population growth, the region is expected to achieve a substantial revenue compound annual growth rate (CAGR) during the forecast period. Factors such as the presence of generic manufacturers and the expansion of healthcare facilities further contribute to the region’s market expansion.
Key highlights of this Market report:
- Growth rate
- Remuneration prediction
- Consumption graph
- Market concentration ratio
- Secondary industry competitors
- Competitive structure
- Major restraints
- Market drivers
- Regional bifurcation
- Competitive hierarchy
- Current market tendencies
- Market concentration analysis
What benefits does the DBMR study is going to provide?
- Latest industry influencing trends and development scenario
- Open up New Markets
- To Seize powerful market opportunities
- Key decision in planning and to further expand market share
- Identify Key Business Segments, Market proposition & Gap Analysis
- Assisting in allocating marketing investments
Table of Contents:
- Introduction
- Market Segmentation
- Executive Summary
- Premium Insights
- Market Regulations
- Market Overview
Continued…
Browse Detailed Summary of Research Report with TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-panic-disorders-market&Shri
Panic Disorders Market Regional Analysis/Insights
The panic disorders market is analysed and market size insights and trends are provided by country, type, therapy and devices, drug class, distribution channel, administration, treatment, dosage, and end-user, as referenced above.
The countries covered in the panic disorders market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina, and rest of South America as part of South America.
U.S. is expected to dominate the market and will continue to flourish its trend of dominance during the forecast period in North America. The major factors attributable to the region’s dominance are the availability of treatment options and rising healthcare costs, which would also contribute to the region’s market’s faster revenue growth. Additionally, the market for panic disorder in the region is anticipated to grow in revenue due to rising awareness of the disease and these other factors.
Asia-Pacific will have the highest growth rate during the forecast period due to changing lifestyles, westernization, and modernization, particularly in developing nations. So, the market is expected to flourish. Additionally, a significant rise in overall population in nations such as China and India, Asia Pacific is anticipated to experience a substantial revenue CAGR during the forecast period. Additional factors that are anticipated to contribute to the market’s revenue growth over the forecast period include the presence of generic manufacturers and the expansion of healthcare facilities in the area.
Key Benefits of the Report:
- This study presents the analytical depiction of this industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of this market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed this industry analysis based on competitive intensity and how the competition will take shape in the coming years.
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
